Genetic Factors Related with Early Onset of Osteonecrosis of the Jaw in Patients with Multiple Myeloma Under Zoledronic Acid Therapy

被引：0
作者：
Melea, Pelagia [1 ]
Bagratuni, Tina [2 ]
Terpos, Evangelos [2 ]
Eleutherakis-Papaiakovou, Evangelos [2 ]
Gavriatopoulou, Maria [2 ]
Melakopoulos, Ioannis [1 ]
Kastritis, Efstathios [2 ]
Dimopoulos, Meletios A. [2 ]
机构：
[1] Henry Dunant Hosp, Athens, Greece
[2] Univ Athens, Sch Med, Athens 11528, Greece
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy
    Kastritis, Efstathios
    Melea, Pelagia
    Bagratuni, Tina
    Melakopoulos, Ioannis
    Gavriatopoulou, Maria
    Roussou, Maria
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    LEUKEMIA & LYMPHOMA, 2017, 58 (10) : 2304 - 2309
  • [2] Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid
    Cetiner, Sedat
    Sucak, Gulsan Turkoz
    Kahraman, Sevil Altundag
    Aki, Sahika Zeynep
    Kocakahyaoglu, Benay
    Gultekin, Sibel Elif
    Cetiner, Mustafa
    Haznedar, Rauf
    JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (04) : 435 - 443
  • [3] Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid
    Sedat Cetiner
    Gulsan Turkoz Sucak
    Sevil Altundag Kahraman
    Sahika Zeynep Akı
    Benay Kocakahyaoglu
    Sibel Elif Gultekin
    Mustafa Cetiner
    Rauf Haznedar
    Journal of Bone and Mineral Metabolism, 2009, 27 : 435 - 443
  • [4] Osteonecrosis of the jaw in patients with multiple myeloma during and after treatment with zoledronic acid
    Calvo-Villas, Jose Manuel
    Torres, Maria Tapia
    Rodriguez, Jose Govantes
    de Granda, Elena Carreter
    Guillen, Francisco Sicilia
    MEDICINA CLINICA, 2006, 127 (15): : 576 - 579
  • [5] Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: Definition and management of the risk related to zoledronic acid
    Cafro, Anna Maria
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (02) : 111 - 116
  • [6] A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma
    Corso, A.
    Varettoni, M.
    Zappasodi, P.
    Klersy, C.
    Mangiacavalli, S.
    Pica, G.
    Lazzarino, M.
    LEUKEMIA, 2007, 21 (07) : 1545 - 1548
  • [7] A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma
    A Corso
    M Varettoni
    P Zappasodi
    C Klersy
    S Mangiacavalli
    G Pica
    M Lazzarino
    Leukemia, 2007, 21 : 1545 - 1548
  • [8] Zoledronic acid-related osteonecrosis of the jaw
    Reactions Weekly, 2023, 1967 (1) : 11 - 11
  • [9] Risk factors for bisphosphonate-related osteonecrosis of jaw in multiple myeloma patients
    Cafro, A. M.
    Babarano, L.
    Nichelatti, M.
    D'Avanzo, G.
    Gaglioti, D.
    Taroni, A.
    Riva, F.
    Nosari, A.
    Andriani, A.
    Morra, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 215 - 216
  • [10] Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid
    Borras-Blasco, J.
    Rosique-Robles, D.
    Giner-Marco, V.
    Galan-Brotons, A.
    Castera, E.
    Costa, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (06) : 651 - 654
12345